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Abstract  13 
Bovine colostrum (COL) has been advocated as a nutritional countermeasure to 14 
exercise-induced immune dysfunction. The aims of this study were to identify the 15 
effects of 4 weeks of COL supplementation on neutrophil responses and mucosal 16 
immunity following prolonged exercise. In a randomised double-blind, parallel group 17 
design, participants (age 28 ± 8 years; body mass [BM] 79 ± 7 kg; height 182 ± 6 cm; 18 
maximal oxygen uptake [ !VO2  max] 55 ± 9 mL·kg-
1·min-1) were assigned to 20 g per 19 
day of COL (n = 10) or an isoenergetic/isomacronutrient placebo (PLA) (n = 10) for 4 20 
weeks. Venous blood and unstimulated saliva samples were obtained before and 21 
after 2.5 h of cycling at 15% Δ (~ 55-60% !VO2  max). A significantly greater fMLP-22 
stimulated oxidative burst was observed in the COL group compared with PLA group 23 
(p < 0.05) and a trend toward a time × group interaction (p = 0.06). However, there 24 
was no effect of COL on leukocyte trafficking, PMA-stimulated oxidative burst, 25 
bacterial-stimulated neutrophil degranulation, salivary secretory IgA, lactoferrin or 26 
lysozyme (p > 0.05). These findings provide further evidence of the beneficial effects 27 
of COL on receptor-mediated stimulation of neutrophil oxidative burst in a model of 28 
exercise-induced immune dysfunction. 29 
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Introduction  33 
It is now well established that exercise of a strenuous and/or prolonged nature can 34 
lead to significant transient perturbations of immune function (commonly referred to 35 
as immunodepression) which includes, but is not limited to, decreases in both cell-36 
mediated and mucosal parameters (Nieman, 2007). This ‘‘open window’’ period of 37 
immune dysfunction has long been hypothesised to contribute to the frequency of 38 
symptoms of upper respiratory illness (URI) in individuals exposed to prolonged 39 
exercise on a regular basis (Gleeson, 2007, Walsh et al., 2011). Various nutritional 40 
interventions have been investigated as strategies to minimise immune perturbations 41 
and URI risk following prolonged exercise, but the majority lack evidence to support 42 
their use (Gunzer et al., 2012).  43 
Bovine colostrum (COL) is the initial milk produced by a cow in the first few days 44 
following parturition. Our laboratory, and others, have reported reduced incidence of 45 
URI in exercising populations during periods of COL supplementation (20 - 60 g·day-46 
1) (Brinkworth & Buckley, 2003; Jones et al., 2014). The mechanism(s) behind such 47 
effects remain unclear but it has been proposed that COL acts as a nutritional 48 
countermeasure to perturbations in immune cell functions and salivary    49 
antimicrobial peptides (AMPs) following acute exercise (Davison, 2013). However, 50 
there remains a lack of investigations on the effects of COL on specific parts of the 51 
human immune system in a post-exercise state. 52 
Animal and in vitro culture studies provide evidence of direct effects of COL on 53 
phagocytosis and oxidative burst of polymorphonuclear cells (i.e. neutrophils) 54 
(Benson et al., 2012; Sugisawa et al., 2001, 2003).  Neutrophils form a critical part of 55 
the human body’s first line of defence as the most abundant leukocyte in the 56 
circulation. While blood neutrophil count is increased following an acute bout of 57 
prolonged exercise (> 1.5 h), the killing mechanisms (production of cytotoxic reactive 58 
oxygen species and release of hydrolytic enzymes) per neutrophil are reduced 59 
(Gleeson, 2007). Previous work in our laboratory showed that 4 weeks of COL (20 60 
g·day-1) supplementation can limit the immunodepressive effects of an acute 61 
physical stressor (2 h of cycling) by enhancing neutrophil stimulated-degranulation 62 
(elastase release) post-exercise (Davison and Diment, 2010). However, little is 63 
known about the effects of COL supplementation on other aspects of neutrophil 64 
functional capacity (e.g. neutrophil oxidative burst) under such physical exertion.  65 
Enhancement or restoration of mucosal defences following exercise may be of 66 
relevance to host defence against URI due to proximity to sites where most 67 
pathogens enter the body (i.e. respiratory tract). COL supplementation has been 68 
shown to prevent prolonged exercise-induced decrements of salivary lysozyme 69 
(sLys) concentration and secretion (Davison and Diment, 2010). Given the 70 
importance of mucosal immune parameters towards host defence (West et al., 71 
2010), further investigation of the effects of COL on other salivary AMPs (e.g. 72 
salivary lactoferrin, sLac) is warranted. Salivary secretory SIgA is the immune 73 
marker which has been most studied as a risk factor for URI during exercise training 74 
(Walsh et al., 2011). COL supplementation for 2-12 weeks has been shown to 75 
increase resting levels of SIgA (Crooks et al., 2006; Mero et al., 2002), an immune 76 
modulation proposed to be an important underlying mechanism of reduced URI with 77 
COL. This hypothesis has not been confirmed and a change in resting output of 78 
salivary SIgA (concentration and/or secretion) is not consistently reported (Crooks et 79 
al., 2010; Jones et al., 2014). Despite lower incidence of URI during 12 weeks of 80 
COL supplementation, we did not observe any significant increases in SIgA 81 
concentration or secretion rate in active males (Jones et al., 2014). This supports 82 
proposals that the effect of COL on host defence may occur through other (or a 83 
combination of) mechanisms (Shing et al., 2007). There are, however, a limited 84 
number of studies that have investigated the effect of COL on SIgA responses and 85 
other markers of immune function following prolonged exercise. Indeed, it is 86 
apparent that the magnitude of change in immunity immediately following each bout 87 
of strenuous exercise may have more clinical implications than training-induced 88 
alterations in resting immunity (Abbasi et al., 2013; Nieman et al., 1994; Pedersen 89 
and Bruunsgaard, 1995). Therefore, the primary aim of this study was to determine 90 
the effects of 4 weeks of COL supplementation on neutrophil oxidative burst 91 
following prolonged cycling with secondary aims to investigate responses of 92 
neutrophil degranulation and salivary AMPs.  93 
Materials and methods  94 
Participants 95 
Twenty healthy, recreationally active males (age 28 ± 8 years; body mass [BM] 79 ± 96 
7 kg; height 182 ± 6 cm; maximal oxygen uptake [ !VO2max] 55 ± 9 mL·kg
-1·min-1) 97 
volunteered to participate in this investigation. Aberystwyth University Research 98 
Ethics Committee approved all experimental procedures prior to the recruitment of 99 
any participants. Participants provided both verbal and written consent following 100 
information on experimental procedures. All participants were non-smokers, non-101 
allergic to dairy products and reported no symptoms of infection or taking any 102 
medication or dietary supplements 4 weeks prior to commencement of study. All 103 
laboratory visits involving exercise also required completion of a physical activity 104 
readiness questionnaire. 105 
Supplementation 106 
Participants were randomly assigned to a COL group (n = 10, age: 29 ± 8 years, BM: 107 
79 ± 8 kg, height: 183 ± 6 cm, !VO2  max 54 ± 9 mL·kg
-1·min-1) or a placebo (PLA) 108 
group (n = 10, age: 27 ± 9 years, BM: 78 ± 8 kg, height: 180 ± 7 cm, !VO2  max 56 ± 9 109 
mL kg-1·min-1). In a double blind manner, participants were asked to consume 20 g 110 
per day (split into a morning and evening 10 g dose on an empty stomach) of COL 111 
(Neovite UK, London) or an isoenergetic/isomacronutrient PLA (as used in Davison 112 
and Diment, 2010) for 4 weeks (28 days). 113 
Preliminary testing 114 
On day 14 of the study period (where day 0 is the day on which baseline samples 115 
were obtained (see below) and supplementation of COL or PLA was commenced), 116 
gas exchange threshold (GET) and !VO2max were determined via a continuous 117 
incremental test (30 W·min-1 ramp rate following 3 min of unloaded baseline 118 
pedalling) to volitional exhaustion on an electrically braked cycle ergometer (Lode 119 
Excalibur, Groningen, The Netherlands). Throughout the duration of the incremental 120 
test, expired gas was analysed by the use of an online breath-by-breath gas analysis 121 
system (Jaeger Oxycon Pro, Hoechberg, Germany). The test was terminated when 122 
the participant’s cadence fell 10 rpm below their preferred cadence for more than 10 123 
s as used previously (Davison and Diment, 2010). For each participant !VO2  max was 124 
determined by the highest 30 s average during the test. GET was estimated for each 125 
participant via the V-slope method (Lansley et al., 2011). The exercise intensity was 126 
set to the power output that would elicit 15% Δ (15% of the difference between power 127 
output at GET and !VO2  max) which was equivalent to ~ 55-60% of the participant’s128 
!VO2  max. The use of % Δ was used to provide a stricter control on the relative 129 
intensity and limit inter-subject variability in physiological responses (Lansley et al., 130 
2011). On day 21, a familiarisation trial took place to accustom participants to the 131 
testing procedures and physical stress expected in the main experimental trial. 132 
Participants performed a 2.5 h exercise bout on the electronically braked cycle 133 
ergometer (specified above) at an intensity of 15% Δ. Expired gas was analysed 134 
during the 10th, 30th, 60th, 90th and 120th min of exercise to verify that the selected 135 
workrate did elicit the target intensity. Heart rate (HR) and RPE were monitored 136 
every 15 min during the protocol using a telemetric device (Polar S610, Polar Electro 137 
Oy, Kempele, Finland) and Borg scale respectively.  138 
  139 
Experimental trial procedures 140 
On day 28 of the study, participants completed the main experimental trial. During 141 
the 48 h preceding the experimental trial, participants were asked to refrain from 142 
heavy exercise and alcohol consumption. On the morning of the experimental trial, 143 
participants reported to the laboratory at 09:00 after an overnight fast of at least 10 h. 144 
The participants were asked to consume 500 mL of water 2 h before arrival to 145 
encourage euhydration. Participants remained seated for 10 min prior to collection of 146 
a resting blood sample from an antecubital vein and an unstimulated saliva sample 147 
(see details on sampling below). Following collection of samples, participants 148 
immediately commenced 2.5 h of cycling at 15% Δ. All participants were permitted 149 
diluted cordial (four volumes of water to 1 volume of sugar-free cordial at 2 mL·min-1 150 
kg of BM) every 15 min during the exercise but not at end of the exercise (to limit 151 
contamination to saliva samples). Expired gas was analysed during the 30th, 60th, 152 
90th and 120th min of exercise (Jaeger Oxycon Pro, Hoechberg, Germany). HR and 153 
RPE were monitored every 15 min during the protocol. Participants remained fasted 154 
for further blood and saliva samples immediately and 1 h post-exercise.  155 
Blood sampling 156 
Participants remained seated, performing minimal movement for 10 min prior to each 157 
blood sample with the exception of immediately post-exercise samples which were 158 
drawn within a few min of exercise cessation. Blood was collected prior to 159 
commencing the above supplementation (Baseline, day 0), pre-exercise, post-160 
exercise and 1 h post-exercise.  Blood samples were collected by venepuncture 161 
(with a 21 gauge precision needle [Becton-Dickinson, Oxford, UK]) from an 162 
antecubital vein into vacutainers (Becton-Dickinson, Oxford, UK) containing 163 
tripotassium ethylene diamine tetraacetic acid (K3EDTA) or lithium heparin. 164 
Haemoglobin, total and differential leukocyte counts were measured in each K3EDTA 165 
vacutainer using an automated haematology analyser (Pentra 60 C+ Haematology 166 
analyser, HORIBA Medical, Montpellier, France). Haematocrit was determined from 167 
an aliquot of whole blood (heparin anti-coagulated) by a standard microcentrifugation 168 
method (using a Hawksley microcentrifuge). This was used along with the previously 169 
attained haemoglobin concentration, to estimate changes in blood and plasma 170 
volume from pre- to post-exercise as previously described (Dill and Costill, 1974). 171 
The remaining blood in heparin vacutainers were centrifuged at 1500 g for 10 min at 172 
4°C with subsequent plasma being stored at -80°C for later analysis of plasma 173 
lactate and glucose concentrations using an automated analyser (YSI 2300 Stat 174 
Plus, Yellow Springs, Ohio, USA) and measurement of unstimulated elastase using 175 
an enzyme-linked immunosorbent assay (ELISA) kit (Merck Calibiochem, Darmstadt, 176 
Germany). 177 
In vitro blood neutrophil function 178 
Whole blood from the K3EDTA treated tubes at pre-exercise, post-exercise and 1 h 179 
post-exercise was placed in a microcentrifuge tube and stored at room temperature 180 
(no longer than 2 h) prior to measurement of in vitro stimulated neutrophil oxidative 181 
burst response to PMA and/or fMLP using a commercially available 182 
chemiluminescence (CL) kit (ABEL, Knight Scientific Ltd, Plymouth, UK) in 183 
accordance with previous studies (Davison et al., 2012). The sample was diluted as 184 
described below before (~ 5 min) commencing the assay. The CL per well was 185 
measured by a microplate luminometer (FLUOstar OPTIMA, BMG Labtech, 186 
Aylesbury, UK). The contents of each microplate well that contained a stimulated 187 
sample were as follows: 10 µL of diluted whole blood (blood and Hank’s balanced 188 
salt solution; HBSS, without calcium and magnesium, at ratio of 1:100), 90 µL assay 189 
buffer (HBSS with calcium and magnesium), 50 µL Pholasin and 20 µL adjuvant K 190 
(substance that enhances the luminescence of Pholasin during assays involving 191 
diluted whole blood).  192 
These mixtures were gently shaken and incubated at 37°C for 30 s in the 193 
luminometer, prior to the addition of 20 µL of PMA (5 µg mL-1) or 20 µL fMLP (10 µm) 194 
to provide an end total volume of 200 µL per well, a 1:1010 final blood dilution and a 195 
PMA or fMLP concentration of 0.5 µg·mL-1 or 1µM respectively. The doses of fMLP 196 
and PMA for these assays are supramaximal in order to provide responses that are 197 
reproducible (attributable to neutrophils only) and prevent any rate limiting effect 198 
from utilisation of the stimulants. PMA penetrates the cell (independent of a 199 
receptor), triggering a long lasting, strong stimulation via protein kinase C and 200 
activation of NADPH oxidase throughout the cell. In contrast, fMLP, induces a rapid 201 
but short, receptor-dependent stimulation of neutrophils via activation of NADPH 202 
oxidase at the cell membrane. Although unstimulated samples in the PMA assay 203 
were also placed through similar mixing and incubation as the stimulated wells, 110 204 
µL of HBSS was added to wells to ensure that the end volume of each well was 205 
standardised (replacing the combination of 90 µL HBSS and PMA). In all samples 206 
which were stimulated by PMA, CL was recorded in duplicate as relative light units 207 
(RLU) at 20 s intervals for 30 min and the area under the CL curve was calculated. 208 
The area under the unstimulated CL curve for each sample was subtracted from the 209 
mean area of the duplicate stimulated sample to determine the PMA-stimulated CL. 210 
When fMLP was the stimulant used, CL was recorded every second for 300 s. The 211 
unstimulated state in the fMLP was calculated as the mean CL of the well during the 212 
initial 2 s prior to addition of fMLP. The area above the stable unstimulated state was 213 
used to determine fMLP-stimulated CL. 214 
To account for oxidative burst responses on a per cell basis, it was assumed that the 215 
CL responses were attributable largely to the neutrophils within the samples 216 
(Morozov et al., 2003). Thus, PMA-stimulated and fMLP-stimulated area under the 217 
CL curve were divided by the number of neutrophils present in each well to give CL 218 
in RLU (i.e. oxidative burst response) per neutrophil. To facilitate inter-subject 219 
comparisons, post-exercise and 1 h post-exercise stimulated oxidative burst 220 
responses were expressed as a percentage of the pre-exercise value, in accordance 221 
with Davison et al. (2012).  222 
Whole blood (primarily via leukocytes) may contribute to exercise-induced increases 223 
in ROS and a state of oxidative stress. In accordance with Davison et al. (2012) the 224 
unstimulated 30 min CL responses from the PMA oxidative burst assay were 225 
expressed per L of whole blood to provide a measure of spontaneous CL (a 226 
snapshot of the level of ROS). This would allow for an investigation of the effect of 227 
COL on the antioxidant potential of whole blood following exercise.  228 
The neutrophil degranulation response was assessed in accordance with Davison 229 
and Diment (2010). The measurement of neutrophil degranulation involved adding 1 230 
mL of the heparinised blood sample to microcentrifuge tubes containing 50 µL of 231 
bacterial stimulant (840-15, Sigma, Poole, UK). The tubes were initially mixed by 232 
gentle inversion before being incubated at 37°C for 1 h. All tubes were gently mixed 233 
halfway through the incubation period. Following incubation, the tubes were 234 
centrifuged for 2 min at 16,000 g, with the supernatant being immediately removed 235 
and stored at -80°C until further analysis. Upon thawing at room temperature, 236 
neutrophil degranulation response was based on measuring the amount of 237 
stimulated elastase release per neutrophil using an ELISA kit (Merck Calibiochem, 238 
Darmstadt, Germany). Bacterial-stimulated elastase release was based on 239 
subtracting elastase concentration of unstimulated samples (heparinised plasma at 240 
same timepoint) away from stimulated samples. The unstimulated samples were 241 
processed immediately to provide background plasma elastase concentration at the 242 
specific timepoint (i.e. not incubated alongside stimulated samples). 243 
Saliva sampling 244 
Participants remained seated, performing minimal movement for 10 min prior to each 245 
saliva sample with the exception of immediately post-exercise samples which were 246 
obtained within a few minutes of exercise cessation. Saliva samples were collected 247 
following blood samples at baseline, pre-exercise, post-exercise and 1 h post-248 
exercise. For all saliva samples the mouth was rinsed with plain water at least 10 249 
min before the collection period. The participant was requested to swallow in order to 250 
empty the mouth before each saliva sample. To obtain the sample, the participant 251 
remained seated with the head tilted slightly forward and passively dribbling into a 252 
pre weighed 7 mL sterile bijou tube while keeping orofacial movement to a minimum. 253 
The final duration of collection was recorded and the tube was re-weighed to allow 254 
for calculation of saliva flow rate when the density of saliva was assumed to be 1.0 255 
g·ml-1 as used previously (Davison and Diment, 2010).  256 
After collection of saliva, samples were centrifuged for 5 min at 16,000 g to pellet 257 
debris leaving the remaining clear supernatant to be aliquoted and stored at – 80°C 258 
for later analysis. All saliva samples were thawed at room temperature only once 259 
prior to analysis. Following the thawing of saliva, samples were again centrifuged for 260 
5 min at 16,000 g to precipitate mucins and other debris and allow for the resulting 261 
clear supernatant to be analysed. With the use of a freezing point depression 262 
osmometer (Osmomat 030, Gonotec, GmbBH, Berlin, Germany), saliva osmolality 263 
was determined to allow for concentration of salivary immunological parameters to 264 
be expressed relative to saliva osmolality. 265 
Aliquots of saliva were screened for blood contamination by the determination of 266 
salivary transferrin concentration using an ELISA kit (Salivary blood contamination 267 
enzyme immunoassay kit, Salimetrics, State College, Pennsylvania, USA). If salivary 268 
transferrin concentration was greater than 1 mgdL-1, the sample was considered to 269 
be contaminated with blood and all other salivary data for that sample was excluded 270 
(except SIgA due to assay being specific to secretory IgA and hence not affected by 271 
blood contamination) from the study. 272 
Salivary secretory IgA and antimicrobial peptides 273 
The concentration of salivary SIgA (mgL-1) and antimicrobial peptides were 274 
determined in accordance with the methods of Jones et al. (2014). Briefly, diluted 275 
saliva supernatants (1:8000 with phosphate buffered saline, PBS) were analysed 276 
using a sandwich enzyme-linked immunosorbent assay (ELISA) approach (specific 277 
to the secretory component of human IgA). Following a 1000 and 8000 fold dilution 278 
of saliva supernatants (with PBS) commercially available ELISA kits were used to 279 
measure the concentration of sLac and sLys respectively (Assaypro LLC, St-Louis, 280 
MO).  281 
Statistical analysis 282 
Data shown in the text, tables and figures are presented as mean ± standard 283 
deviation unless stated otherwise. Statistical analysis of all data was performed via 284 
the statistical computer software package SPSS (v20.00; SPSS Inc., Chicago, IL, 285 
USA). Initially, a two factor mixed ANOVA (group × time) was carried out on 286 
immunological measures to determine if the effect of time was different between 287 
COL and PLA (group). Any significant main effects of time identified in the ANOVA 288 
were further analysed by post hoc 2 tailed paired t-tests with Holm-Bonferoni 289 
correction. Independent t-tests were used to determine any significant differences 290 
between groups in HR, oxygen uptake ( !VO2 ) or RPE during the main experimental 291 
trial. Statistical significance was accepted at p < 0.05. 292 
Results  293 
Physiological variables and RPE 294 
There was no significant difference in !VO2  expressed in either absolute terms (p = 295 
0.479) or relative to !VO2  max (; p = 0.445) between the COL (2406 ± 187 mL·min
-1; 296 
57 ± 4% !VO2  max) and PLA trial (2497 ± 351 mL·min
-1; 58 ± 4% !VO2  max). There 297 
was no difference (p = 0.989) in HR between COL (73 ± 2%) and PLA (74 ± 3%) 298 
trials when expressed as a proportion of peak HR obtained during the incremental 299 
test !VO2  max determination. There was also no significant difference in RPE (p = 300 
0.158) between the COL (12.4 ± 1.9) and PLA (13.5 ± 1.2) trial. 301 
Similar patterns of plasma volume changes were observed from pre-exercise 302 
between trials: COL; post-exercise (-6.4 ± 4.8%); 1 h post-exercise (-3.1 ± 6.0) and 303 
PLA; post-exercise (-4.5 ± 2.7%), 1 h post-exercise (-1.7 ± 3.3%). As there was no 304 
significant difference between trials (group ˣ time interaction; p = 0.697), it was 305 
deemed unnecessary to correct any haematological parameters for plasma volume 306 
changes. Although there was a significant change across time (p = 0.004), there was 307 
no significant group (p = 0.937) or interaction effect (p = 0.771) on plasma glucose. 308 
Post hoc analysis revealed a significantly lower plasma glucose at 1 h post-exercise 309 
(COL: 4.29 ± 0.46 mmolL-1, PLA: 4.28 ± 0.33 mmolL-1) compared to both pre-310 
exercise (COL: 4.87 ± 0.34 mmolL-1, PLA: 4.79 ± 0.31 mmolL-1, p < 0.001) and 311 
post-exercise (COL: 4.54 ± 0.86 mmolL-1, PLA: 4.59 ± 0.52 mmolL-1, p = 0.031). 312 
There was also a significant change across time for plasma lactate (p = 0.002) but 313 
no effect of group (p = 0.796) or interaction (p = 0.751). Plasma lactate significantly 314 
increased from pre-exercise (COL: 1.36 ± 0.28 mmolL-1, PLA: 1.49 ± 0.46 mmolL-1) 315 
to post-exercise (COL: 1.93 ± 0.67 mmolL-1, PLA: 2.01 ± 0.73 mmolL-1, p 0.014) 316 
before decreasing towards resting levels at 1 h post-exercise (COL: 1.54 ± 0.56 317 
mmolL-1, PLA: 1.46 ± 0.28 mmolL-1, p = 1.000).  318 
Circulating total and differential cell counts 319 
There was no time × group interaction effect or main effect of group on circulating 320 
total leukocytes, neutrophils, lymphocytes, monocytes, and neutrophil:lymphocyte 321 
ratio (Table 1). A main effect of time (p < 0.001) was observed in all leukocyte counts 322 
(Table 1). There was a significant increase in total leukocytes, neutrophils, 323 
monocytes, neutrophil:lymphocyte ratio from timepoints pre-exercise (Baseline and 324 
pre-exercise) to post-exercise (p ≤ 0.01) and 1 h post exercise (except lymphocytes) 325 
(p < 0.01). Total lymphocyte count significantly increased from baseline to post-326 
exercise (p = 0.022). There was a significant increase in neutrophils, 327 
neutrophil:lymphocyte ratio (p < 0.001) and decrease in total lymphocytes (p < 328 
0.001) and monocytes (p = 0.036) from post-exercise to 1 h post-exercise. 329 
  330 
 Neutrophil responses 331 
Two-way mixed ANOVA revealed a significant main effect of time (p < 0.001) for 332 
fMLP-stimulated CL per neutrophil (neutrophil oxidative burst) (Fig. 1A). There was a 333 
significant decrease in fMLP-stimulated CL per neutrophil from pre-exercise to post-334 
exercise (p = 0.001) and 1 h post-exercise (p < 0.001). There was a main effect of 335 
group for fMLP-stimulated CL per neutrophil (p = 0.049) and an interaction effect 336 
(group ˣ time) which approached significance (p = 0.060, Fig. 1A). 337 
A significant main effect of time (p < 0.001) was observed for PMA-stimulated CL per 338 
neutrophil (neutrophil oxidative burst) (Fig. 1B). There was a significantly higher 339 
PMA-stimulated CL per neutrophil at pre-exercise compared with post-exercise (p < 340 
0.001) and 1 h post-exercise (p = 0.001). There was a significant increase in PMA-341 
stimulated CL per neutrophil from post to 1 h post-exercise (p = 0.014). There was 342 
no main effect of group (p = 0.395) or group ˣ time interaction (p = 0.464) for PMA-343 
stimulated CL per neutrophil (Fig. 1B).  344 
A significant main effect of time (p < 0.001) was observed for CLL-1 blood (Table 2). 345 
There was a significant increase in spontaneous CLL-1 blood compared to pre-346 
exercise at post-exercise (p < 0.001) and 1 h post-exercise (p = 0.001). 347 
Spontaneous CLL-1 blood significantly decreased from post-exercise to 1 h post-348 
exercise (p = 0.014). There was no main effect of group (p = 0.071) or group ˣ time 349 
interaction (p = 0.539) for spontaneous CLL-1 blood (Table 2).  350 
There was no significant main effect of time (p = 0.629), group (p = 0.538) or group ˣ 351 
time interaction (p = 0.687) for stimulated elastase release per neutrophil (neutrophil 352 
degranulation) (Table 2).  353 
Mucosal responses 354 
There were no significant main effects of group or group × time interaction for 355 
salivary SIgA or antimicrobial peptides when expressed as absolute concentration, 356 
secretion rate or relative to saliva osmolality (Supporting Information Table S1-S2).  357 
There was no significant main effect of time for salivary SIgA concentration (p 358 
=0.903) or salivary SIgA secretion rate (p = 0.430) (Supporting Information Table 359 
S1). There was, however, a main effect of time saliva SIgA:osmolality (p < 0.001) 360 
with post hoc analysis showing a significantly decreased saliva SIgA:osmolality from 361 
baseline and pre-exercise to post-exercise (p < 0.001) and an increase towards 362 
resting levels from post-exercise to 1 h post-exercise (p = 0.022). 363 
Blood contamination was detected in the saliva samples from six participants, three 364 
in each group, leaving n = 7 in each group for analysis of sLac and sLys responses. 365 
There was a significant main time effect for sLac concentration (p < 0.001, 366 
Supporting Information Table S2) with post hoc analysis showing that sLac 367 
concentration was increased at post-exercise compared to baseline (p < 0.001) and 368 
pre-exercise (p = 0.002) followed by a decrease from post-exercise to 1 h post-369 
exercise (p = 0.005). A main effect of time was also revealed for sLac secretion rate 370 
(p < 0.001) but not  sLac:osmolality (p = 0.405),  (Supporting Information Table S2). 371 
Post hoc analysis identified greater sLac secretion rate at post-exercise (p < 0.001) 372 
and 1 h post-exercise (p = 0.030) compared to baseline as well as an increase from 373 
pre-exercise to post-exercise (p =0.026).  374 
A significant main effect of time was reported for sLys concentration (p = 0.003) 375 
(Supporting Information Table S2), post hoc analysis revealed increases in sLys 376 
concentration from baseline to post-exercise (p = 0.012). There was a main effect of 377 
time (p = 0.009) for sLys secretion rate but no effect on sLys:osmolality (p = 0.127)  378 
(Supporting Information Table S2). Post hoc analysis revealed an increase in sLys 379 
secretion rate from baseline to 1 h post-exercise (p = 0.023).   380 
Discussion 381 
The present study demonstrated that 4 weeks of COL supplementation results in 382 
greater attenuation of the decline in fMLP-oxidative burst responses compared to 383 
PLA in a model of exercise-induced immune dysfunction. This is the first study to 384 
investigate the effects of COL on the responses of this innate immune parameter to 385 
prolonged exercise. We did not, however, observe beneficial effects of 4 weeks COL 386 
supplementation on other innate and mucosal parameters in this study.  387 
Similar to other investigations of prolonged exercise, there were significant increases 388 
in circulating leukocytes, neutrophils, lymphocytes, neutrophil:lymphocyte, and 389 
monocytes (Davison et al., 2012; Li and Gleeson, 2005; McCarthy and Dale, 1988). 390 
In line with previous evidence (Carol et al., 2011; Davison and Diment, 2010), there 391 
were no differences between the COL and PLA groups for leukocyte trafficking to 392 
exercise. Taken together, these studies suggest that any effects of COL on exercise-393 
induced changes in immune function are not related to the attenuation of the 394 
perturbations in leukocytes that occur as a result of increases in catecholamine or 395 
hypothalamic–pituitary–adrenal axis activation (e.g. leukocytosis) (McCarthy and 396 
Dale, 1988).  397 
The findings of in vitro culture demonstrate that COL possesses the ability to prime 398 
neutrophil function (Benson et al., 2012; Sugisawa et al., 2001, 2003). Neutrophils 399 
can be primed by a range of cytokines (granulocyte macrophage colony-stimulating 400 
factor, granulocyte colony-stimulating factor, interleukin-8, tumour necrosis factor α) 401 
which amplify responses to subsequent stimulation (Elbim et al., 1994). Sugisawa et 402 
al. (2003) proposed that ‘priming’ induced by COL is due to low molecular weight 403 
substances (e.g. proteose peptones) other than cytokines. Although further 404 
investigations into the role of cytokines or proposed bioactive peptides are required, 405 
the findings here suggest that consumption of COL does increase the bioavailability 406 
of components which enhance receptor mediated neutrophil oxidative activity (e.g. 407 
fMLP). Jensen et al. (2012) observed an increase in phagocytic activity from 408 
baseline in human polymorphonuclear cells obtained at 1 h and 2 h following 409 
consumption of a low-molecular weight fraction of COL. It is currently unclear how 410 
long any priming effect of COL may last  but it has previously been reported that 411 
enhanced oxidative burst responses to fMLP can last ≥ 24 h following exposure to 412 
priming agents (e.g. G-CSF) (Ichinose et al., 1990). It can, however, be suggested 413 
from the findings presented here that the underlying mechanism(s) of COL 414 
supplementation are, at least, not due to a modulation of antioxidant capacity due to 415 
a lack of effect on spontaneous oxidative burst activity.  416 
This study showed no attenuation of exercise-induced decreases in PMA-stimulated 417 
oxidative burst with COL supplementation. Therefore, COL may not exert effects on 418 
neutrophil responses via protein kinase C (PKC) and/or does not affect the maximal 419 
capacity of neutrophils following prolonged exercise. Although the activation of PKC 420 
has been shown to occur following stimulation by some physiological agonists 421 
(Peake, 2002), PMA is not encountered in vivo and hence considered as an artificial 422 
stimulus (Sheppard et al., 2005). Due to the irreversible nature of PMA stimulation, it 423 
differs substantially to physiological agonists (e.g. fMLP) (DeCoursey and Ligeti, 424 
2005). The effectiveness of PMA to stimulate pathways for ROS production in vitro 425 
has perhaps masked the irrelevancy of the agonist towards in vivo neutrophil 426 
function (Sheppard et al., 2005). In contrast, production of formylated proteins (e.g. 427 
fMLP) is attributed to bacteria and mitochondria, where a receptor (FPR1) on the cell 428 
surface of neutrophils recognises microbial moieties and tissue damage (Jaillon et 429 
al., 2013). Thus, the potential in vivo significance of enhanced fMLP-induced 430 
oxidative burst by COL supplementation may be enhanced responses toward 431 
infectious and/or inflammatory challenge (Zhang et al., 2010).  432 
Despite the exercise-induced fall in neutrophil oxidative burst, there was no effect of 433 
prolonged exercise on neutrophil stimulated-elastase release. This is in contrast to 434 
some (Davison et al., 2012; Laing et al., 2008) but not other previous investigations 435 
(Li and Gleeson, 2005). The comparison of this study to others is, however, limited 436 
by the lack of measurement in potential mediators (e.g. stress hormones, cytokines) 437 
but it is reasonable to suggest that the exercise stress, in particular the exercise 438 
intensity, was not sufficient to induce decrements in neutrophil degranulation 439 
observed in other studies (Davison et al., 2012; Laing et al., 2008). Furthermore, the 440 
findings of this study may support the hypothesis that oxidative burst capacity may 441 
be more susceptible to the duration rather than exercise intensity per se (Peake, 442 
2002).  443 
The absence of a fall in neutrophil degranulation (bacterial-stimulated elastase) in 444 
this study (hence a reduced scope for nutritional intervention) may also explain why 445 
there was a discrepancy to effects observed with 4 weeks of supplementation in 446 
Davison and Diment (2010). The azurophilic granules of neutrophils are also 447 
abundant in AMPs e.g. lysozyme. In contrast, to Davison and Diment (2010), there 448 
was also no enhancement in sLys within the present study. It is worthy to note that 449 
the large variability in sLys responses to exercise in this study is in accordance with 450 
others (West et al., 2010) who have recognised the variance as a source of limitation 451 
for the detection of intervention induced-changes in mucosal parameters, particularly 452 
in a parallel groups design. As shown previously (Allgrove & Gleeson, 2014), there 453 
was an increased availability of sLac following prolonged exercise in both COL and 454 
PLA groups. The reason for this increase remains unclear but may be indicative of 455 
an inflammatory response induced by damaged epithelial cells (Davison et al., 456 
2009). Given that longitudinal studies of sLac have observed lower levels in athletes 457 
compared to resting controls (West et al., 2010), further investigations are required 458 
to determine whether responses to prolonged exercise on a regular basis leads to a 459 
depletion of sLac availability. This study and previous evidence from our laboratory 460 
(Jones et al., 2014), suggest that COL does not influence sLac availability either in a 461 
resting state or in response to acute stress. 462 
Reduced mobilisation of salivary SIgA has been advocated as a marker of 463 
dysfunctional mucosal immunity following prolonged exercise (Walsh et al., 2011). 464 
Despite no change in concentration or secretion, there was an exercise-induced 465 
decrease in saliva SIgA:osmolality that was unaltered by COL supplementation. The 466 
majority of previous studies have investigated the effects of COL on resting salivary 467 
SIgA concentrations whereby some report increases (Crooks et al., 2006; Mero et 468 
al., 2002) whereas other investigators have found little evidence of changes with 469 
supplementation (Crooks et al., 2010; Davison and Diment, 2010; Jones et al., 470 
2014;). Based on Mero et al. (2002), Davison and Diment (2010) proposed that the 471 
dosage of COL may need to be split across the day or taken over longer periods to 472 
stimulate changes in resting salivary SIgA production. Although not separated into 473 
four doses (5 g each) as done by Mero et al. (2002), the present study did split the 474 
COL dosage into a morning and evening dose (10 g each). The variance in results, 475 
to date, may be explained by the composition of the COL and the assay used in the 476 
determination of IgA. As large variability in salivary SIgA may also be a confounding 477 
factor here, further studies with exercise protocols that combine both high-intensity 478 
and long duration exercise, thus associated with greater impact (i.e. depressive) on 479 
salivary SIgA output are required to clarify the effect of COL on exercise-induced 480 
changes in this mucosal parameter.  481 
In conclusion, the primary finding of the study was that COL supplementation has 482 
beneficial effects on receptor dependent (fMLP-stimulated) oxidative burst responses 483 
to prolonged exercise. There was, however, no effect of COL on all other parameters 484 
of innate and mucosal immunity, although it is possible that larger 485 
decreases/immunodepression is required for a benefit in these measures to become 486 
apparent. Further research is required to determine this and also elucidate the 487 
mechanisms underlying the effects of COL supplementation in order to define the 488 
optimal timing and/or dosage of COL.  489 
Perspectives 490 
This study is the first to demonstrate that COL supplementation better preserves 491 
stimulated oxidative burst responses of human blood neutrophils following prolonged 492 
exercise. Neutrophils form a critical part of the human body’s first line of defence as 493 
the most abundant circulating leukocyte. Once described as a short-lived effector 494 
cell, the role of the neutrophil is now known to extend beyond the elimination of 495 
microorganisms and is now considered a major cell type involved in orchestrating an 496 
immune response (Scapini & Cassatella, 2014). In addition to recurrent bacterial 497 
infections observed in those with genetic neutrophil disorders (Summers et al., 498 
2010), the innate cell is receiving increased recognition as a key mediator of host 499 
defence against viral infections (e.g. influenza) in otherwise healthy populations 500 
(Drescher & Bai, 2013). The overall significance of the augmentation in neutrophil 501 
function with COL supplementation in terms of athletes’ resistance to pathogens is 502 
still to be determined. We have previously shown that COL supplementation limited 503 
increases in salivary bacterial load in physically active males (at rest) during the 504 
winter months which coincided with decreases in incidence of URI (Jones et al., 505 
2014). Indeed, the beneficial effects of COL were most evident during periods of 506 
greater prevalence of URI (hence a greater scope for intervention). It was suggested 507 
that participants were exposed to fewer or shorter transient immune perturbations as 508 
a result of COL supplementation which may limit conditions for changes in resident 509 
microorganisms and/or susceptibility to invading pathogens. Given the complexity of 510 
the immune system, it is unlikely that one immune parameter alone would explain 511 
changes in URI risk with COL supplementation, thus the importance of other immune 512 
markers (at rest or following strenuous exertion) need to be determined. Further 513 
investigation of neutrophils to clarify the underlying mechanisms of COL 514 
supplementation on human host defence is warranted. This study goes some way to 515 
achieving this by providing important new evidence regarding the potential for COL 516 
in priming receptor-mediated neutrophil responses to bacterial stimulation.  517 
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Table 1. Blood immune cell counts in COL and PLA groups 630 
Significant main effect of time *p < 0.001). 631 

























Total leukocytes    0.528 
COL 4.91 ± 1.10 5.14 ± 1.07 11.46 ± 5.73 11.13 ± 4.47 < 0.001* 
PLA 5.33 ± 1.60 5.62 ± 1.37 11.95 ± 4.39 11.51 ± 3.62 0.965 
Neutrophils    0.611 
COL 2.57 ± 0.81 2.50 ± 1.28 7.84 ± 4.14 8.32 ± 3.81 < 0.001* 
PLA 2.48 ± 0.79 2.78 ± 0.83 8.45 ± 3.74 8.78 ± 3.36 0.679 
Monocytes    0.899 
COL 0.43 ± 0.15 0.52 ± 0.12 0.95 ± 0.58 0.84 ± 0.43 < 0.001* 
PLA 0.50 ± 0.23 0.54 ± 0.12 0.79 ± 0.22 0.72 ± 0.21 0.336 
Total lymphocytes    0.622 
COL 1.65 ± 0.46 1.90 ± 0.71 2.41 ± 1.12 1.77 ± 0.46 0.001* 
PLA 2.02 ± 0.68 2.02 ± 0.58 2.32 ± 0.57 1.69 ± 0.33 0.278 
Neutrophil:lymphocyte    0.883 
COL 1.61 ± 0.61 1.45 ± 0.72 3.36 ± 1.21 4.74 ± 1.90 < 0.001* 
PLA 1.32 ± 0.48 1.45 ± 0.50 3.70 ± 1.46 5.35 ± 2.33 0.176 
Table 2. Spontaneous ROS production and stimulated degranulation responses and 633 
in COL or PLA groups. 634 
Significant main effect of time *p < 0.001). 635 
Fig. 1 fMLP (A) and PMA (B) stimulated chemiluminescence per neutrophil following 636 
4 weeks of COL or PLA. Significant change from pre-exercise: *p = 0.001, **p < 637 
0.001. #Significant change from post-exercise (p < 0.05). †Significant main effect of 638 
group for fMLP-stimulated chemiluminescence per neutrophil (p < 0.05). 639 





















Spontaneous CLL-1 blood   0.071 
COL 813 ± 193 1110 ±  323 1042 ± 326         < 0.001* 
PLA 1114 ± 335 1502 ± 537     1309 ± 467 0.539 
Stimulated elastase release per neutrophil (fgcell-1) 0.538 
COL 369 ± 85 428 ± 310 374 ± 159 0.629 
PLA 444 ± 144 396 ± 166 447 ± 233 0.687 
 641 
Fig. 1 642 
